Table: Taiko Pharmaceutical -Q1 group results

Taiko Pharmaceutical

10/08/2017 08:00

Aug 10 (Reuters)-  
             Taiko Pharmaceutical Co Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                   3 months ended      3 months ended       Year to  
                  Jun 30, 2017        Jun 30, 2016     Mar 31, 2018  
                     LATEST             YEAR-AGO          LATEST     
                     RESULTS             RESULTS         FORECAST    
  Sales               1.40                1.04             8.70      
                   (+34.3 pct)         (-27.2 pct)      (+4.9 pct)   
  Operating          181 mln              3 mln            1.55      
                                       (-97.5 pct)      (+0.4 pct)   
  Recurring          128 mln           loss 91 mln         1.30      
                                                        (-7.6 pct)   
  Net                99 mln            loss 35 mln        900 mln    
                                                        (-14.2 pct)  
  EPS               7.07 yen          loss 2.71 yen      63.74 yen   
  EPS Diluted       7.05 yen                                         
  Ann Div                               20.00 yen        15.00 yen   
  -Q2 div                                  NIL              NIL      
  -Q4 div                               20.00 yen        15.00 yen   
   
  NOTE - Taiko Pharmaceutical Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4574.T  
  ((Tokyo Headline News Desk +813 6441 1812))